2024 SV Therapeutics Impact & ESG Report
Read More
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
Read More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
SV News
3 May 2017Portfolio NewsDDF to Invest $5 Million in Cerevance to Seek New Treatments for Dementia
1 May 2017Portfolio NewsAligned Telehealth Names Dan Castillo President and COO
27 April 2017Portfolio NewsArsanis Completes $45.5 Million Series D Financing- 11 April 2017SV NewsSV Health Investors Closes on New Fund Focused on Creating and Growing Companies That Advance Science and Transform Healthcare
- 10 April 2017SV NewsSV Life Sciences Changes Name to SV Health Investors to Better Reflect the Firm's Longstanding Strategy and Focus
15 March 2017Portfolio NewsAutifony Therapeutics obtains £1.3 million in funding from Innovate UK and the Dementia Discovery Fund to explore novel approach to treatment of dementia
28 February 2017SV NewsDDF Acquires Small Molecule Library and Enters Strategic Partnership with Aptuit to Kickstart Dementia Drug Discovery Programmes
27 January 2017SV NewsKate Bingham receives BIA Lifetime Achievement Award at Annual Gala Dinner
21 October 2016Portfolio NewsLaunch of Dementia Discovery Fund New Fund Raises $100 Million to Deliver Novel Approaches to Treatment of Dementia- 3 June 2016Portfolio NewsDDF invests in Gen2 Neuroscience Ltd
- 25 January 2016SV NewsSV appoints world-renowned Chief Scientific Officer to lead the new DDF investment team
7 January 2016Portfolio NewsDDF Makes First Investment In Alector LLC
